Mostrando 8 resultados de: 8
Filtros aplicados
Subtipo de publicación
Article(8)
Publisher
Biotecnologia Aplicada(3)
Food Hydrocolloids(1)
Investigacion Clinica (Venezuela)(1)
Revista Cubana de Farmacia(1)
Revista Mexicana de Urologia(1)
Área temáticas
Enfermedades(6)
Farmacología y terapéutica(3)
Medicina y salud(2)
Problemas sociales y servicios a grupos(2)
Cirugía y especialidades médicas afines(1)
Origen
google(7)
Diagnostic value of alpha-fetoprotein for hepatocellular carcinoma
ArticleAbstract: Hepatocellular carcinoma (HCC) variously occupies the fifth or sixth position as the most frequent nPalabras claves:Alpha-fetoprotein, Cirrhosis, Hepatocelular carcinomaAutores:Cruz Y., Fernández I., Hernández J.C., I. Howland-Álvarez, Ivón Howland-Álvarez, Roque A., Samada M.Fuentes:googlescopusFormation and stability of shark liver oil loaded chitosan/calcium alginate capsules
ArticleAbstract: Calcium alginate capsules containing shark liver oil were prepared by ionotropic gelation of alginatPalabras claves:Alginate, Chitosan, Encapsulation, Shark liver oilAutores:Argüelles-Monal W., Carrillo O., I. Howland-Álvarez, Ivón Howland-Álvarez, Peniche Covas C., Zaldívar C.Fuentes:googlescopusEpidemiological characteristics of a group of multi-organ donors used to transplant organs in Cuba
ArticleAbstract: Introduction. For current transplants, the organ donor is a basic factor. Objectives. To determine tPalabras claves:Brain death, donors, liver transplant, Multiorgan donors, Serology studies, TransplantAutores:Abdo-Cuza A., Álvarez-Plasencia A., Castellanos-Becerril F., Castellanos-Gutiérrez R., Cruz-Gómez Y., García-Navarro M.E., Gómez-Peyre F., I. Howland-Álvarez, Ivón Howland-Álvarez, Parellada-Blazco J., Rafael-Truy B., Suárez-Savio O., Verdecia-Gorrita N.Fuentes:googlescopusGrowth Hormone Releasing Peptide 6 (GHRP6) reduces liver fibrosis in CCl4 chronically intoxicated rats
ArticleAbstract: Tissue fibrosis is a leading cause of morbidity and mortality. Current treatments for conditions sucPalabras claves:Carbon tetrachloride, Cirrhosis, Cytoprotection, FIBROSIS, GHRP6, Liver, SecretagogueAutores:Abreu A., Berlanga-Acosta J., Bringas R., Cibrín D., Cintado A., Coro-Antich R., Cosme-Díz K., Cruz Y., Fernández-Massó J.R., García-del Barco D., González-Ferrer Y., Guillén I., Guillén-Nieto G.E., I. Howland-Álvarez, Inés L., Ivón Howland-Álvarez, León-Fernández O.S., López-Mola E., Mendoza-Marí Y., Miranda J., Nazabal M., Ochagavía M.E., Palenzuela D., Suaréz J., Ugarte-Moreno D., Vázquez-Blomquist D., Vila J.M.Fuentes:googlescopusIgg4 related diseases. A case report in Ecuador and review of the literature
ArticleAbstract: The IgG4-related disease (IgG4-RD) can involve multiple organs, generating fibrous-inflammatory tissPalabras claves:Clinic aspects, diagnosis, IgG4 disease, inflammationAutores:Alisson Muñoz Mendoza, German Josuet Lapo-Talledo, Héctor Quintero Montaño, I. Howland-Álvarez, Ivón Howland-Álvarez, María Ayala García, Mónica Guerrero Madroñero, Navarrete-Sornoza D.Fuentes:googlescopusRenal involvement associated with weak monoclonal components in Cuban patients with monoclonal gammopathy
ArticleAbstract: Objective: To analyze the relationship between the monoclonal bands detected in serum protein electrPalabras claves:Immunofixation, Kidney failure, Monoclonal gammopathy, Protein electrophoresisAutores:Cruz-Gómez Y., I. Howland-Álvarez, Ivón Howland-Álvarez, Jorge G. Zambrano-MeraFuentes:googlescopusPotential drug-laboratory test interactions in patients hospitalized in an intensive care unit
ArticleAbstract: Introduction: Patients hospitalized in an intensive care unit are under treatment with multiple drugPalabras claves:Clinical laboratory tests, drugs, interactionsAutores:Ángel Aurelio Marcillo Vélez, Briggitte Lilibeth Cedeño Mendoza, Danaisy Cabrera Montes de Oca, I. Howland-Álvarez, Ivón Howland-Álvarez, Mirna C. OviedoFuentes:scopusPreclinical safety demonstration of the human recombinant erythropoietin HEBERITRO®
ArticleAbstract: Erythropoietin (EPO) is a glycoprotein that appears in blood as a response to hypoxia, acting on bonPalabras claves:EPREX®, erythropoietin, Preclinical toxicology, safetyAutores:Bacardí D.M., Cosme K., Gutiérrez A., I. Howland-Álvarez, Ivón Howland-Álvarez, Merino N., Pérez-Caballero M., Porras D.N., Suaréz J., Urquiza D., Vázquez A.Fuentes:googlescopus